Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Cancer Biother Radiopharm. 2008 Aug;23(4):411–423. doi: 10.1089/cbr.2007.0450

Figure 1.

Figure 1

Model of the 3S193 tetrameric VL-0-VH single-chain Fv “multimer” construct. The complementary-determining regions for each binding site are shown in yellow. The VH domains are depicted as ribbons, and the VL domains are shown as wires.